Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Pancreatic Neoplasms 8Stomach Neoplasms 6Sarcoma 6Liver Neoplasms 6Neuroectodermal Tumors, Primitive, Peripheral 5Carcinoma, Hepatocellular 5Wilms Tumor 4Rectal Neoplasms 4Ovarian Neoplasms 4Esophageal Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 4Testicular Neoplasms 3Retinoblastoma 3Osteosarcoma 3Neuroblastoma 3Medulloblastoma 3Kidney Neoplasms 3Hepatoblastoma 3Central Nervous System Neoplasms 3Bile Duct Neoplasms 3Astrocytoma 3Testicular Germ Cell Tumor 2Teratoma 2Rhabdoid Tumor 2Ovarian Germ Cell Cancer 2Optic Nerve Glioma 2Neoplasm Metastasis 2Melanoma 2Head and Neck Neoplasms 2

Interventions

lutetium Lu 177 dotatate 8lanreotide 4copper dotatate CU-64 4Octreotide 4177Lu-octreotide, DOTA(0)-Tyr(3)- 4pasireotide 3Magnetic Resonance Spectroscopy 3Lutetium-177 3Lutetium 3gallium Ga 68 dotatate 2amino-acid, glucose, and electrolyte solution 2Temozolomide 2Nivolumab 2Irinotecan 2Ga(III)-DOTATOC 2Everolimus 2Etoposide 2Carboplatin 2zimberelimab 1regorafenib 1pembrolizumab 1irinotecan sucrosofate 1folfirinox 1famitinib 1cabozantinib 1arginyllysine 1abemaciclib 1X-Rays 1Sunitinib 1Somatostatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastro-enteropancreatic neuroendocrine tumor × Filgrastim × Gastrointestinal × Clear all
NCT03042780 2020-11-27

FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
2 enrolled 6 charts
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neoplasm Metastasis, Pancreatic Neoplasms, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡